Documents

A list of downloadable documents created during development.

Invitation to participate

Melanoma (unresectable, metastatic) - pembrolizumab (after ipilimumab) [ID760]: scope consultation comments table

Melanoma (unresectable, metastatic) - pembrolizumab (after ipilimumab) [ID760]: final scope

Melanoma (unresectable, metastatic) - pembrolizumab (after ipilimumab) [ID760]: equality impact assessment

Melanoma (unresectable, metastatic) - pembrolizumab (after ipilimumab) [ID760]: final matrix